Antifungal Susceptibility Patterns of Vulvovaginal Candida species among Women Attending Antenatal Clinic at Mbarara Regional Referral Hospital, South Western Uganda
Kiguli James Mukasa, Itabangi Herbert, Atwine Daniel, Kibuka Livingstone Sserunkuma, Bazira Joel, Byarugaba Frederick
Microbiology Research Journal International · pp. 322–331 · Published 6 Nov 2014
10.9734/BMRJ/2015/13804Abstract
Aims: To identify the Candida species that cause vulvovaginal candidiasis and determine their antifungal susceptibility patterns. Study Design: This was a cross-sectional study. Place and Duration of Study: The study was conducted at the antenatal clinic of Mbarara Regional Referral Hospital in Mbarara Municipality, between December 2012 and February 2013. Methods: High vaginal swabs from 456 pregnant women were subjected to microscopy and culture on Sabouraud Dextrose Agar. Candida isolates were identified by the germ tube and Analytical profile index (API® Candida) tests. Susceptibility to fluconazole, itraconazole and voriconazole was determined by the Etest strips and for clotrimazole and nystatin by the disc diffusion method on Mueller Hinton agar supplemented with 2%w/v glucose and 0.5µg/ml methylene blue dye. Results: Of the 456 High vaginal swabs cultured, 207 grew Candida species. Species distribution was as follows: C. albicans (78.95%), C. glabrata (14.35%), C. krusei (3.35%), C. tropicalis (1.44%), C. famata (0.96%), C. parapsilosis (0.48%) and C. lusitaniae (0.48%). Resistance to nystatin was only observed in 0.61% of C.albicans. Resistance to clotrimazole was observed in 50%, 36.67% and 0.61% of C. famata, C. glabrata and C. albicans respectively. C. krusei showed a high resistance of 71.43% to fluconazole. C. glabrata, C. krusei, C. famata and C. lusitaniae exhibited 100% resistance to itraconazole. Resistance to voriconazole of less than 11% was exhibited by only C. albicans and C. glabrata. Conclusion: C.albicans was susceptible to most antifungal agents tested except itraconazole and voriconazole. All isolates were susceptible to nystatin except less than 1% of Candida albicans. Non-albicans demonstrated resistance to some drugs especially itraconazole. We recommend use of Nystatin for empirical management of vulvovaginal candidiasis among pregnant women.
References (23)
- 1 4 million neonatal deaths: When? Where? Why? [DOI]
- 2 Vulvovaginal candidosis [DOI]
- 3 Microbial Prevalence, Diversity and Abundance in Amniotic Fluid During Preterm Labor: A Molecular and Culture-Based Investigation [DOI]
- 4 Antifungal Susceptibility Testing: Practical Aspects and Current Challenges [DOI]
- 5 Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases [DOI]
- 6 Method for antifungal disk diffusion susceptibility testing of yeasts : Approved guideline
- 7 Prevalence and risk factors for vaginal Candidacolonization in women with type 1 and type 2 diabetes [DOI]
- 8 Antifungal susceptibility testing [DOI]
- 9 Vulvovaginal carriage of yeasts other than Candida albicans [DOI]
- 10 Antifungal Susceptibility Testing: Technical Advances and Potential Clinical Applications [DOI]
- 11 Fluconazole Susceptibility of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical Implications [DOI]
- 12 Prevalence of and risk factors for fungal vaginitis caused by non-albicans species [DOI]
- 13 The distribution frequency of Candida species in the genitourinary tract among symptomatic individuals in Nigerian cities.
- 14 Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis.
- 15 [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
- 16 ANTIFUNGAL SUSCEPTIBILITY TESTING [DOI]
- 17 [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
- 18 Species Distribution and Susceptibility to Azoles of Vaginal Yeasts Isolated Prostitutes [DOI]
- 19 Vulvovaginal candidiasis in Mato Grosso, Brazil: pregnancy status, causative species and drugs tests [DOI]
- 20 Host defense against oropharyngeal and vaginal candidiasis: Site-specific differences.
- 21 Premature delivery due to intrauterine Candida infection that caused neonatal congenital cutaneous candidiasis: A case report [DOI]
- 22 CLINICAL RELEVANCE OF ANTIFUNGAL RESISTANCE [DOI]
- 23 Species distribution and antifungal sensitivity patterns of vaginal yeasts [DOI]
Cited by 71
Luc M'mebwa Mtende, Musa Kasujja, Lionel Musafiri Simba · 2024
Related research
- Knowledge, Attitude and Predisposing Risk Factors of Non-Albican Vulvovaginal Candidiasis among Symptomatic Women in Port Harcourt — shares topic coverage
- Prevalence and Antifungal Susceptibility patterns of Candida Isolated on CHROMagarTMCandida at a Tertiary Referral Hospital, Eastern Uganda — shares topic coverage
- A Hospital-based Study on the Detection of Fluconazole-resistant Candida albicans from Women with Vulvovaginal Candidiasis in Port Harcourt — shares topic coverage
- Correlates of Vulvovaginal Candidiasis among Attendees of a Special Treatment Clinic in Nigeria — shares topic coverage
- Antifungal Resistance Pattern of Candida Species Isolated from High Vaginal Swabs of Women Attending a Hospital in Enugu State, Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
263
Page views
0
PDF downloads
92
Outbound clicks
71
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.